Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ILEVRO 0.3% OPHTH DROPS

nepafenac
$121.0250per ML

Strength

3 mg/mL

Manufacturer

Harrow Eye, LLC

NDC

82667040003

Classification

Brand

Dosage Form

SUSPENSION/ DROPS

Route

OPHTHALMIC

Last Updated

4/22/2026

Active Ingredients

NEPAFENAC

Approval Type

New Drug (NDA)

FDA Application

NDA203491

On Market Since

5/1/2024

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price History

1W

0.0%

1M

-0.1%

3M

-0.1%

6M

-0.2%

1Y

-0.4%

3Y

N/A

5Y

N/A

All

-0.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

CHILDREN'S ADVIL 100 MG/5 ML
Brand
00573017030•Haleon US Holdings LLC
$0.0368
per ML
CHILDREN'S ADVIL 100 MG/5 ML
Brand
00573017130•Haleon US Holdings LLC
$0.0368
per ML
CHILDREN'S ADVIL 100 MG/5 ML
Brand
00573023230•Haleon US Holdings LLC
$0.0368
per ML
CHILDREN'S ADVIL 100 MG/5 ML
Brand
00573029030•Haleon US Holdings LLC
$0.0368
per ML
ADVIL 200 MG TABLET
Brand
00573015020•Haleon US Holdings LLC
$0.1081
per EA
ADVIL 200 MG TABLET
Brand
00573015030•Haleon US Holdings LLC
$0.1081
per EA
ADVIL 200 MG TABLET
Brand
00573015040•Haleon US Holdings LLC
$0.1081
per EA
ADVIL 200 MG TABLET
Brand
00573015110•Haleon US Holdings LLC
$0.1081
per EA
ADVIL 200 MG TABLET
Brand
00573015475•Haleon US Holdings LLC
$0.1081
per EA
ADVIL 200 MG TABLET
Brand
00573015498•Haleon US Holdings LLC
$0.1081
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy